A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer Meeting Abstract


Authors: Janjigian, Y. Y.; Ku, G. Y.; Ilson, D. H.; Boyar, M. S.; Capanu, M.; Chou, J. F.; Kelsen, D. P.; Imtiaz, T.; Berger, M. F.; Vakiani, E.
Abstract Title: A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab refractory esophagogastric (EG) cancer
Meeting Title: 2015 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 3 Suppl.
Meeting Dates: 2015 Jan 15-17
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-01-20
Language: English
ACCESSION: WOS:000356883800058
PROVIDER: wos
Notes: Meeting Abstract: 59 -- Source: Wos
MSK Authors
  1. Joanne Fu-Lou Chou
    145 Chou
  2. Michelle S Boyar
    3 Boyar
  3. Geoffrey Yuyat Ku
    82 Ku
  4. Marinela Capanu
    189 Capanu
  5. Yelena Yuriy Janjigian
    133 Janjigian
  6. David H Ilson
    258 Ilson
  7. Michael Forman Berger
    373 Berger
  8. Efsevia Vakiani
    161 Vakiani
  9. David P Kelsen
    309 Kelsen
  10. Tooba   Imtiaz
    7 Imtiaz